Qube Research & Technologies (QRT)
OYST

Qube Research & Technologies (QRT)’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio OYST Stock Details OYST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-14,248
Closed -$80K – 3180
2022
Q3 		$80K Buy
+14,248
New +$89.2K ﹤0.01% 2035

Other funds holding OYST

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Qube Research & Technologies (QRT)'s OYST Position: Q4 2022 in Review

Qube Research & Technologies (QRT) sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q4 2022, closing a stake of 14,248 shares — an estimated $80K sold.

Qube Research & Technologies (QRT) first reported a position in OYST in Q3 2022 and held it in 1 quarter. The position peaked at $80K in Q3 2022. 53 funds tracked by Wall St. Rank hold OYST as of Q4 2022.

  • Qube Research & Technologies (QRT) reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 14,248 Oyster Point Pharma, Inc. Common Stock shares in Q4 2022, an estimated $80K.
  • Qube Research & Technologies (QRT) first reported a position in Oyster Point Pharma, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
  • Qube Research & Technologies (QRT)'s Oyster Point Pharma, Inc. Common Stock position peaked at $80K in Q3 2022.
  • 53 funds tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q4 2022.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2022, filed 14 Feb 2023.